Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4034 | 1860 | 47.5 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
285 | 3 | ERDOSTEINE//PEROXIREDOXIN//GLUTATHIONE | 42405 |
870 | 2 | PEROXIREDOXIN//THIOREDOXIN//GLUTATHIONE | 11539 |
4034 | 1 | THIOREDOXIN//BIOL PONSES//THIOREDOXIN REDUCTASE | 1860 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THIOREDOXIN | authKW | 2026934 | 24% | 28% | 444 |
2 | BIOL PONSES | address | 1616521 | 9% | 58% | 169 |
3 | THIOREDOXIN REDUCTASE | authKW | 1597676 | 13% | 41% | 237 |
4 | THIOREDOXIN 1 | authKW | 608841 | 3% | 59% | 63 |
5 | MED NOBEL BIOCHEM | address | 540764 | 4% | 46% | 71 |
6 | THIOREDOXIN INTERACTING PROTEIN | authKW | 439845 | 2% | 62% | 43 |
7 | THIOREDOXIN PROJECT | address | 347340 | 1% | 92% | 23 |
8 | TXNIP | authKW | 278677 | 2% | 41% | 41 |
9 | VDUP1 | authKW | 237193 | 1% | 85% | 17 |
10 | VIRUS | address | 221504 | 11% | 7% | 205 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 6452 | 49% | 0% | 916 |
2 | Endocrinology & Metabolism | 1677 | 13% | 0% | 234 |
3 | Biophysics | 1193 | 10% | 0% | 188 |
4 | Cell Biology | 901 | 13% | 0% | 242 |
5 | Oncology | 406 | 10% | 0% | 180 |
6 | Immunology | 99 | 5% | 0% | 101 |
7 | Biochemical Research Methods | 88 | 3% | 0% | 61 |
8 | Medicine, Research & Experimental | 72 | 4% | 0% | 66 |
9 | Peripheral Vascular Diseases | 57 | 2% | 0% | 45 |
10 | Pharmacology & Pharmacy | 52 | 6% | 0% | 110 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOL PONSES | 1616521 | 9% | 58% | 169 |
2 | MED NOBEL BIOCHEM | 540764 | 4% | 46% | 71 |
3 | THIOREDOXIN PROJECT | 347340 | 1% | 92% | 23 |
4 | VIRUS | 221504 | 11% | 7% | 205 |
5 | BIOMED SPECIAL UNIT | 205184 | 1% | 83% | 15 |
6 | BIOL PONSE | 184662 | 1% | 75% | 15 |
7 | MED BIOCHEM BIOPHYS | 65964 | 6% | 4% | 115 |
8 | INFECT PREVENTSAKYO KU | 52527 | 0% | 80% | 4 |
9 | GIVEN | 51293 | 0% | 63% | 5 |
10 | CLIN SCI H4 526 | 49245 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIOXIDANTS & REDOX SIGNALING | 30706 | 4% | 2% | 76 |
2 | FREE RADICAL BIOLOGY AND MEDICINE | 12767 | 4% | 1% | 82 |
3 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1600 | 7% | 0% | 128 |
4 | REDOX BIOLOGY | 1235 | 0% | 1% | 6 |
5 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1187 | 4% | 0% | 73 |
6 | BIOFACTORS | 913 | 0% | 1% | 9 |
7 | BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 850 | 1% | 0% | 16 |
8 | REDOX REPORT | 845 | 0% | 1% | 7 |
9 | FREE RADICAL RESEARCH | 774 | 1% | 0% | 12 |
10 | METHODS IN ENZYMOLOGY | 688 | 1% | 0% | 27 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THIOREDOXIN | 2026934 | 24% | 28% | 444 | Search THIOREDOXIN | Search THIOREDOXIN |
2 | THIOREDOXIN REDUCTASE | 1597676 | 13% | 41% | 237 | Search THIOREDOXIN+REDUCTASE | Search THIOREDOXIN+REDUCTASE |
3 | THIOREDOXIN 1 | 608841 | 3% | 59% | 63 | Search THIOREDOXIN+1 | Search THIOREDOXIN+1 |
4 | THIOREDOXIN INTERACTING PROTEIN | 439845 | 2% | 62% | 43 | Search THIOREDOXIN+INTERACTING+PROTEIN | Search THIOREDOXIN+INTERACTING+PROTEIN |
5 | TXNIP | 278677 | 2% | 41% | 41 | Search TXNIP | Search TXNIP |
6 | VDUP1 | 237193 | 1% | 85% | 17 | Search VDUP1 | Search VDUP1 |
7 | ADULT T CELL LEUKEMIA DERIVED FACTOR | 181827 | 1% | 92% | 12 | Search ADULT+T+CELL+LEUKEMIA+DERIVED+FACTOR | Search ADULT+T+CELL+LEUKEMIA+DERIVED+FACTOR |
8 | THIOREDOXIN REDUCTASE 1 | 179555 | 1% | 58% | 19 | Search THIOREDOXIN+REDUCTASE+1 | Search THIOREDOXIN+REDUCTASE+1 |
9 | HUMAN THIOREDOXIN | 139039 | 1% | 71% | 12 | Search HUMAN+THIOREDOXIN | Search HUMAN+THIOREDOXIN |
10 | THIOREDOXIN BINDING PROTEIN 2 | 136789 | 1% | 83% | 10 | Search THIOREDOXIN+BINDING+PROTEIN+2 | Search THIOREDOXIN+BINDING+PROTEIN+2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MAHMOOD, DFD , ABDERRAZAK, A , EL HADRI, K , SIMMET, T , ROUIS, M , (2013) THE THIOREDOXIN SYSTEM AS A THERAPEUTIC TARGET IN HUMAN HEALTH AND DISEASE.ANTIOXIDANTS & REDOX SIGNALING. VOL. 19. ISSUE 11. P. 1266 -1303 | 251 | 55% | 67 |
2 | ARNER, ESJ , (2009) FOCUS ON MAMMALIAN THIOREDOXIN REDUCTASES - IMPORTANT SELENOPROTEINS WITH VERSATILE FUNCTIONS.BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. VOL. 1790. ISSUE 6. P. 495 -526 | 199 | 54% | 210 |
3 | LILLIG, CH , HOLMGREN, A , (2007) THIOREDOXIN AND RELATED MOLECULES - FROM BIOLOGY TO HEALTH AND DISEASE.ANTIOXIDANTS & REDOX SIGNALING. VOL. 9. ISSUE 1. P. 25 -47 | 146 | 59% | 321 |
4 | GROMER, S , URIG, S , BECKER, K , (2004) THE THIOREDOXIN SYSTEM - FROM SCIENCE TO CLINIC.MEDICINAL RESEARCH REVIEWS. VOL. 24. ISSUE 1. P. 40-89 | 182 | 59% | 255 |
5 | WATANABE, R , NAKAMURA, H , MASUTANI, H , YODOI, J , (2010) ANTI-OXIDATIVE, ANTI-CANCER AND ANTI-INFLAMMATORY ACTIONS BY THIOREDOXIN 1 AND THIOREDOXIN-BINDING PROTEIN-2.PHARMACOLOGY & THERAPEUTICS. VOL. 127. ISSUE 3. P. 261 -270 | 111 | 85% | 50 |
6 | POWIS, G , MONTFORT, WR , (2001) PROPERTIES AND BIOLOGICAL ACTIVITIES OF THIOREDOXINS.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 41. ISSUE . P. 261 -295 | 138 | 65% | 252 |
7 | POWIS, G , MONTFORT, WR , (2001) PROPERTIES AND BIOLOGICAL ACTIVITIES OF THIOREDOXINS.ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE. VOL. 30. ISSUE . P. 421 -455 | 137 | 65% | 215 |
8 | AN, NF , KANG, YB , (2014) THIOREDOXIN AND HEMATOLOGIC MALIGNANCIES.REDOX AND CANCER, PT A. VOL. 122. ISSUE . P. 245 -279 | 116 | 70% | 0 |
9 | HASHEMY, SI , (2011) THE HUMAN THIOREDOXIN SYSTEM: MODIFICATIONS AND CLINICAL APPLICATIONS.IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES. VOL. 14. ISSUE 3. P. 191 -204 | 107 | 76% | 1 |
10 | MASUTANI, H , YOSHIHARA, E , MASAKI, S , CHEN, Z , YODOI, J , (2012) THIOREDOXIN BINDING PROTEIN (TBP)-2/TXNIP AND ALPHA-ARRESTIN PROTEINS IN CANCER AND DIABETES MELLITUS.JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION. VOL. 50. ISSUE 1. P. 23 -34 | 93 | 74% | 26 |
Classes with closest relation at Level 1 |